More heat to treat fever in subarachnoid hemorrhage?
Citation Manager Formats
Make Comment
See Comments

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Subarachnoid hemorrhage is most often caused by aneurysmal rupture and afflicts up to 33,000 patients in the United States annually. Associated with a 51% case-fatality rate, 20% of patients die before reaching medical care and 30% do not recover from the initial hemorrhage. Treatment requires both surgical and medical intervention. Surgically, the ruptured aneurysm is secured via craniotomy or endovascular technique in order to prevent rebleeding. Optimal clinical recovery requires medical treatment in an intensive care setting, where nimodipine can be administered and the patient monitored for early recognition of intracranial hypertension, hydrocephalus, and cerebral vasospasm. In cases of vasospasm, institution of triple H therapy—i.e., hypertensive, hypervolemic, hemodilution—may be warranted. Infection, venous thrombosis, and malnutrition may also exacerbate recovery.1,2
Fever is also an important consideration in patients with subarachnoid hemorrhage. Fever has long been associated with critical illness, especially if the brain is involved.3 Preclinical studies in animals provide evidence that elevated brain temperature causes an increase in cerebral metabolic demand, which exacerbates an already …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Alert Me
Recommended articles
-
Articles
Anterior communicating artery aneurysm paraparesis syndromeClinical manifestations and pathologic correlatesK. A. Greene, F. F. Marciano, C. A. Dickman et al.Neurology, January 01, 1995 -
Article
Endovascular treatment of cerebral vasospasm after subarachnoid hemorrhageMore is moreRamazan Jabbarli, Daniela Pierscianek, Roland Rölz et al.Neurology, July 05, 2019 -
Articles
Haptoglobin and the development of cerebral artery vasospasm after subarachnoid hemorrhageM. Borsody, A. Burke, W. Coplin et al.Neurology, January 25, 2006 -
Articles
Calcium antagonists in patients with aneurysmal subarachnoid hemorrhageA systematic reviewV. L. Feigin, G.J.E. Rinkel, A. Algra et al.Neurology, April 01, 1998